Laurel Edelman

Laurel is an executive leader with diverse experience in the healthcare sector; bridging pharma, biotech, device manufacturers and government. She has been instrumental in expanding the use of novel healthcare data assets in public health, including influenza surveillance for a key federal agency. Laurel is published in the areas of influenza and RSV surveillance systems, and she is accredited for developing strategic blueprints to guide leading life sciences companies in developing business practices, policies, and technology solutions. She previously led business development for IMS Government Solutions (now IQVIA, NYSE:IQV) leveraging healthcare data and informatics to assist Government decision makers in civilian healthcare policy, research, and operations.